Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Nov 12 2020

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 3 pages · English

Release

Cadila Healthcare Limited has informed the Exchange regarding a press release dated November 12, 2020, titled "Zydus successfully completes Phase II clinical trials with Pegylated Interferon alpha-2b in India; the Company to start Phase III clinical trials".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases